Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)

13. november 2026 opdateret af: University Hospital, Limoges

A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital

SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.

The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).

A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.

Studieoversigt

Status

Rekruttering

Betingelser

Detaljeret beskrivelse

Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.

Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.

Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.

Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.

This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.

Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.

Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.

Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.

Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.

The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

70

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.

Beskrivelse

Inclusion Criteria:

  • Age 18 years or older.
  • Patients undergoing elective cholecystectomy.
  • Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
  • Patients able to complete questionnaires independently or with the assistance of a caregiver.
  • Patients covered by a health insurance scheme.
  • Patients who have not objected to participation in the study.

Exclusion Criteria:

  • Patients undergoing emergency surgery.
  • Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
  • Patients with a history of chronic gastrointestinal disease.
  • Patients with known gallbladder cancer.
  • Patients scheduled for open laparotomy.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Patients undergoing elective cholecystectomy

Adult patients undergoing elective cholecystectomy at Limoges University Hospital

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Proportion of patients with a visual analogue scale (VAS) pain
Tidsramme: From two hours after surgery to four weeks postoperatively.

Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

From two hours after surgery to four weeks postoperatively.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Proportion of patients with a VAS pain score
Tidsramme: Two hours after surgery.

Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy.

Two hours after surgery.
Proportion of patients experiencing early postoperative complications
Tidsramme: Up to four weeks after surgery.

Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification.

Up to four weeks after surgery.
Description of intraoperative pain management techniques
Tidsramme: During surgery

Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block .

For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable.

During surgery
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Tidsramme: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2)

Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
Change in the EQ-5D-5L visual analogue scale (VAS)
Tidsramme: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2).

Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
Description of patient-reported experience using the study-specific PREMS questionnaire
Tidsramme: Postoperative assessment at 3 to 6 weeks (T2)

Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item.

Postoperative assessment at 3 to 6 weeks (T2)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Niki CHRISTOU, Professor, University Hospital, Limoges

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

13. juni 2025

Primær færdiggørelse (Anslået)

13. juni 2027

Studieafslutning (Anslået)

13. juni 2028

Datoer for studieregistrering

Først indsendt

30. oktober 2026

Først indsendt, der opfyldte QC-kriterier

13. november 2026

Først opslået (Faktiske)

17. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

17. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

13. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 87RI24_0064 (SATISCHOL)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .